{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-14",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "69729-789",
      "generic_name": "Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin USP, Phenylephrine Hydrochloride",
      "labeler_name": "OPMX LLC",
      "brand_name": "Pentrexcilina Children TOTAL RELIEF Multi-Symptom",
      "active_ingredients": [
        {
          "name": "PHENYLEPHRINE HYDROCHLORIDE",
          "strength": "5 mg/10mL"
        },
        {
          "name": "ACETAMINOPHEN",
          "strength": "250 mg/10mL"
        },
        {
          "name": "DEXTROMETHORPHAN HYDROBROMIDE",
          "strength": "13.33 mg/10mL"
        },
        {
          "name": "GUAIFENESIN",
          "strength": "200 mg/10mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "69729-789-06",
          "description": "1 BOTTLE in 1 CARTON (69729-789-06)  / 177 mL in 1 BOTTLE",
          "marketing_start_date": "20250115",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {},
      "marketing_category": "OTC MONOGRAPH DRUG",
      "dosage_form": "SYRUP",
      "spl_id": "5c3fa411-4ef3-312d-e063-6394a90a0783",
      "product_type": "HUMAN OTC DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20250115",
      "product_id": "69729-789_5c3fa411-4ef3-312d-e063-6394a90a0783",
      "application_number": "M012",
      "brand_name_base": "Pentrexcilina Children TOTAL RELIEF Multi-Symptom",
      "pharm_class": [
        "Adrenergic alpha1-Agonists [MoA]",
        "Decreased Respiratory Secretion Viscosity [PE]",
        "Expectorant [EPC]",
        "Increased Respiratory Secretions [PE]",
        "Sigma-1 Agonist [EPC]",
        "Sigma-1 Receptor Agonists [MoA]",
        "Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]",
        "Uncompetitive NMDA Receptor Antagonists [MoA]",
        "alpha-1 Adrenergic Agonist [EPC]"
      ]
    }
  ]
}